Cognitive behavioural therapy without medication for schizophrenia

CONCLUSIONS: This review is the first attempt to systematically synthesise the evidence about CBT delivered without medication to people with schizophrenia. The limited number of studies and low to very low certainty of the evidence prevented any strong conclusions. An important limitation in the available studies was that participants in the CBT without medication group (about 35% on average) received antipsychotic treatment, highlighting the challenges of this approach. Further high-quality RCTs are needed to provide additional data on the feasibility and efficacy of CBT without antipsychotics.PMID:38323679 | PMC:PMC10848293 | DOI:10.1002/14651858.CD015332.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Source Type: research